186 related articles for article (PubMed ID: 20631911)
1. Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products.
Takino J; Yamagishi S; Takeuchi M
J Oncol; 2010; 2010():739852. PubMed ID: 20631911
[TBL] [Abstract][Full Text] [Related]
2. Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression.
Takino J; Yamagishi S; Takeuchi M
World J Gastroenterol; 2012 Apr; 18(15):1781-8. PubMed ID: 22553402
[TBL] [Abstract][Full Text] [Related]
3. Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction.
Sotokawauchi A; Nakamura N; Matsui T; Higashimoto Y; Yamagishi SI
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283652
[TBL] [Abstract][Full Text] [Related]
4. Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients.
Mao Z; Baker JR; Takeuchi M; Hyogo H; Tjønneland A; Eriksen AK; Severi G; Rothwell J; Laouali N; Katzke V; Kaaks R; Schulze MB; Palli D; Sieri S; de Magistris MS; Tumino R; Sacerdote C; Derksen JWG; Gram IT; Skeie G; Sandanger TM; Quirós JR; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Guevara M; Harlid S; Johansson I; Perez-Cornago A; Freisling H; Gunter M; Weiderpass E; Heath AK; Aglago E; Jenab M; Fedirko V
Int J Cancer; 2023 Jun; 152(11):2257-2268. PubMed ID: 36715363
[TBL] [Abstract][Full Text] [Related]
5. The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.
Takino J; Kobayashi Y; Takeuchi M
J Gastroenterol; 2010 Jun; 45(6):646-55. PubMed ID: 20084527
[TBL] [Abstract][Full Text] [Related]
6. Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products.
Matsui T; Joo HD; Lee JM; Ju SM; Tao WH; Higashimoto Y; Fukami K; Yamagishi S
Immunol Lett; 2015 Oct; 167(2):141-6. PubMed ID: 26304702
[TBL] [Abstract][Full Text] [Related]
7. Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia.
Takeda M; Ohnuma T; Takeuchi M; Katsuta N; Maeshima H; Takebayashi Y; Higa M; Nakamura T; Nishimon S; Sannohe T; Hotta Y; Hanzawa R; Higashiyama R; Shibata N; Gohda T; Suzuki Y; Yamagishi S; Tomino Y; Arai H
Neurosci Lett; 2015 Apr; 593():51-5. PubMed ID: 25766756
[TBL] [Abstract][Full Text] [Related]
8. Presence of glyceraldehyde-derived advanced glycation end-products in the liver of insulin-resistant mice.
Ebata Y; Takino J; Tsuchiya H; Sakabe T; Ikeda Y; Hama S; Kogure K; Takeuchi M; Shiota G
Int J Vitam Nutr Res; 2013; 83(2):137-41. PubMed ID: 24491887
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products impair glucose-induced insulin secretion from rat pancreatic β-cells.
Hachiya H; Miura Y; Inoue K; Park KH; Takeuchi M; Kubota K
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):134-41. PubMed ID: 23798335
[TBL] [Abstract][Full Text] [Related]
10. Glyceraldehyde-derived advanced glycation end-products are associated with left ventricular ejection fraction and brain natriuretic peptide in patients with diabetic adverse cardiac remodeling.
Yasuda Y; Aoki H; Fujita W; Fujibayashi K; Wakasa M; Kawai Y; Nakanishi H; Saito K; Takeuchi M; Kajinami K
Scand Cardiovasc J; 2022 Dec; 56(1):208-216. PubMed ID: 35792728
[No Abstract] [Full Text] [Related]
11. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
Takeuchi M; Yamagishi S
Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
[TBL] [Abstract][Full Text] [Related]
12. MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells.
Sakuraoka Y; Sawada T; Okada T; Shiraki T; Miura Y; Hiraishi K; Ohsawa T; Adachi M; Takino J; Takeuchi M; Kubota K
World J Gastroenterol; 2010 Nov; 16(42):5334-41. PubMed ID: 21072897
[TBL] [Abstract][Full Text] [Related]
13. In vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM.
Takino J; Nagamine K; Takeuchi M; Hori T
World J Gastroenterol; 2015 Feb; 21(6):1784-93. PubMed ID: 25684943
[TBL] [Abstract][Full Text] [Related]
14. The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk.
Kong SY; Takeuchi M; Hyogo H; McKeown-Eyssen G; Yamagishi S; Chayama K; O'Brien PJ; Ferrari P; Overvad K; Olsen A; Tjønneland A; Boutron-Ruault MC; Bastide N; Carbonnel F; Kühn T; Kaaks R; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Vasilopoulou E; Masala G; Pala V; Santucci De Magistris M; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Jakszyn P; Sánchez MJ; Dorronsoro M; Gavrila D; Ardanaz E; Rutegård M; Nyström H; Wareham NJ; Khaw KT; Bradbury KE; Romieu I; Freisling H; Stavropoulou F; Gunter MJ; Cross AJ; Riboli E; Jenab M; Bruce WR
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1855-63. PubMed ID: 26404963
[TBL] [Abstract][Full Text] [Related]
15. Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease.
Choei H; Sasaki N; Takeuchi M; Yoshida T; Ukai W; Yamagishi S; Kikuchi S; Saito T
Acta Neuropathol; 2004 Sep; 108(3):189-93. PubMed ID: 15221334
[TBL] [Abstract][Full Text] [Related]
16. The specific localization of advanced glycation end-products (AGEs) in rat pancreatic islets.
Morioka Y; Teshigawara K; Tomono Y; Wang D; Izushi Y; Wake H; Liu K; Takahashi HK; Mori S; Nishibori M
J Pharmacol Sci; 2017 Aug; 134(4):218-224. PubMed ID: 28843667
[TBL] [Abstract][Full Text] [Related]
17. Chebulic acid prevents hepatic fibrosis induced by advanced glycation end-products in LX-2 cell by modulating Nrf2 translocation via ERK pathway.
Koo YC; Pyo MC; Nam MH; Hong CO; Yang SY; Lee KW
Toxicol In Vitro; 2016 Aug; 34():8-15. PubMed ID: 27021876
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in Japan.
Takeuchi M; Takino J; Furuno S; Shirai H; Kawakami M; Muramatsu M; Kobayashi Y; Yamagishi S
PLoS One; 2015; 10(3):e0118652. PubMed ID: 25730321
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.
Dong Z; Iwata D; Kitaichi N; Takeuchi M; Sato M; Endo N; Iwabuchi K; Ando R; Fukuhara J; Kinoshita S; Lennikov A; Kitamura M; Mizuuchi K; Kanda A; Noda K; Namba K; Yamagishi S; Ohno S; Ishida S
J Leukoc Biol; 2014 Dec; 96(6):1077-85. PubMed ID: 25201803
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.
Katagiri M; Shoji J; Inada N; Kato S; Kitano S; Uchigata Y
Int Ophthalmol; 2018 Apr; 38(2):607-615. PubMed ID: 28299499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
